KR20100091284A - Cosmetic composition included neolitsea aciculata extraction - Google Patents

Cosmetic composition included neolitsea aciculata extraction Download PDF

Info

Publication number
KR20100091284A
KR20100091284A KR1020090010402A KR20090010402A KR20100091284A KR 20100091284 A KR20100091284 A KR 20100091284A KR 1020090010402 A KR1020090010402 A KR 1020090010402A KR 20090010402 A KR20090010402 A KR 20090010402A KR 20100091284 A KR20100091284 A KR 20100091284A
Authority
KR
South Korea
Prior art keywords
extract
cosmetic composition
activity
skin
neolitsea
Prior art date
Application number
KR1020090010402A
Other languages
Korean (ko)
Other versions
KR101100129B1 (en
Inventor
이남호
김상숙
Original Assignee
제주대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제주대학교 산학협력단 filed Critical 제주대학교 산학협력단
Priority to KR1020090010402A priority Critical patent/KR101100129B1/en
Publication of KR20100091284A publication Critical patent/KR20100091284A/en
Application granted granted Critical
Publication of KR101100129B1 publication Critical patent/KR101100129B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: A cosmetic composition containing Neolitsea aciculata extract is provided to ensure anti-wrinkle, anti-oxidation, and skin whitening. CONSTITUTION: A cosmetic composition contains 0.0001-10.0 weight% of Neolitsea aciculate extract as an active ingredient. The extract is isolated using methanol or ethanol. The Neolitsea aciculate extract is a fraction extract which is obtained by fractioning with hexane, ethylacetate, butanol, and water in order. The cosmetic composition is used in the form of lotion, essence, cream, pack, foundation, gel, ointment, or spray.

Description

새덕이나무 추출물을 유효성분으로 함유하는 화장료 조성물{COSMETIC COMPOSITION INCLUDED NEOLITSEA ACICULATA EXTRACTION}Cosmetic composition containing sapling as an active ingredient {COSMETIC COMPOSITION INCLUDED NEOLITSEA ACICULATA EXTRACTION}

본 발명은 새덕이나무 추출물을 유효성분으로 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing the sapwood as an active ingredient.

인간 노화의 근본적인 원인을 해결하고자 현대과학에서는 다양한 방법으로 그 연구를 진행하고 있으며 점점 삶이 윤택해지면서 신체의 내적인 노화뿐만 아니라 외적인 부분에 발행하는 노화를 막고자 하는 관심이 증대되고 있다. In order to solve the root cause of human aging, modern science is conducting its research in various ways, and as life gets better, there is increasing interest in preventing aging issued to external parts as well as internal aging of the body.

특히, 인간의 외적 노화 연구에서는 피부를 이용해서 많은 연구가 진행되고 있다.In particular, in the external aging studies of humans, many studies are being conducted using skin.

피부의 노화에는 시간이 경과함에 따라 기관과 동반하여 피부의 구조와 기능이 지속적으로 감퇴되어지는 내인성노화(chronologic aging)와 장기간에 걸친 태양광선의 노출로 인한 피부조직의 변화인 외인성노화(Photoaging)가 있다. The aging of the skin is called aging, which is a change in skin tissue due to chronologic aging and the prolonged exposure of sunlight to the skin. There is.

이러한 노화 과정으로 피부가 건조해지면서, 주름이 생기고 피부는 탄력을 잃게 된다.As the skin ages, the skin gets wrinkles and the skin loses its elasticity.

피부노화에 관한 연구에서 가장 중요하게 다루어지는 것은 자유 전자기(free radical)와 활성산소종(Reactive oxigen species)이다. The most important issues addressed in the study of skin aging are free radicals and reactive oxigen species.

이들은 자연적으로 생체 내에서 만들어지기도 하지만 공해, 태양 자외선, 화학 산화제 및 미생물등에 의해 발생되어진다.They are naturally produced in vivo, but are caused by pollution, solar ultraviolet rays, chemical oxidants, and microorganisms.

이때 발생되어진 자유전자기나 활성산소종은 피부세포에 산화적 스트레스를 가하게 되고, 이러한 과정에서 생긴 물질은 멜라닌과 주름 생성의 원인물질로 여겨진다.The free electrons or free radicals generated at this time exert oxidative stress on the skin cells, and the material produced in this process is considered to be the cause of melanin and wrinkle formation.

이들 활성 산소종은 효소적, 비효소적 항산화제로 이루어진 피부 항산화 방어막을 붕괴시키고 생체분자의 산화적 변형, 피부 장벽의 손상과 결합조직인 콜라겐, 히아루론산 등의 사스절단 및 비정상적인 교차결합에 의한 주름생성 등 피부노화를 가속 시킨다.These reactive oxygen species break down the skin's antioxidant defenses made of enzymatic and non-enzymatic antioxidants, oxidative modification of biomolecules, damage to the skin barrier, cuts of connective tissue collagen and hyaluronic acid, and wrinkles caused by abnormal crosslinking. Accelerates skin aging

한편, 멜라닌 생성 혹은 멜라노사이트의 증식에 의해 야기되는 색소 침착은 다양한 방법으로 억제가 가능하다. On the other hand, pigmentation caused by melanin production or melanocyte growth can be suppressed in various ways.

일반적으로는 멜라닌합성의 중요한 효소인 티로시나제(Tyrosinase) 활성억제, 멜라노사이트의 기능감소, 자동산화 반응의 억제를 통한 멜라닌 생성의 감소, 홍반과 같은 염증반응 억제등 다양한 경로를 이용할 수 있다.In general, various pathways such as inhibition of tyrosinase activity, an important enzyme of melanin synthesis, decreased function of melanocytes, reduction of melanin through inhibition of automatic oxidation, and inhibition of inflammatory reactions such as erythema are available.

결과적으로 피부노화 방지를 위해서는 과잉의 활성 산소종 생성을 억제하고 또한 생성된 활성산소를 효율적으로 제거할 수 있어야하며, 피부의 주름을 일으키는 효소들의 억제, 색소침착을 진행하는 효소의 활성억제 등에 관한 연구가 필요하다. As a result, in order to prevent skin aging, it is necessary to suppress the generation of excess active oxygen species and to efficiently remove the generated free radicals, and to inhibit the enzymes that cause wrinkles on the skin and inhibit the activity of the enzymes that proceed with pigmentation. Need research

이에, 아래와 같이 피부노화 및 미백관련해서 식물을 이용한 연구가 시행되 어 왔다.Thus, researches using plants in relation to skin aging and whitening have been conducted as follows.

한국등록특허공보 제10-0874115호(백리향 추출물을 유효성분으로 함유하는 화장료 조성물)에는, 항산화효과, 피부노화 방지효과, 피부주름 개선효과, 미백효과를 갖는 백리향 추출물을 함유한 화장료 조성물에 관한 것이 공개되어 있다.Korean Patent Publication No. 10-0874115 (cosmetic composition containing thyme extract as an active ingredient) relates to a cosmetic composition containing a thyme extract having an antioxidant effect, skin anti-aging effect, skin wrinkle improvement effect, whitening effect It is open.

한국등록특허공보 제10-0863267호(허브 추출물을 포함하는 피부 상태 개선용 조성물)에는, 인삼, 황기, 감초, 흑축, 녹차 및 알로에 추출물을 유효성분으로 포함하여 미백효과, 피부단력 및 주름개선 효능을 갖는 피부 개선용 조성물에 관한 것이 공개되어 있다.Korean Patent Publication No. 10-0863267 (composition for improving skin condition containing herbal extracts), including ginseng, Astragalus, licorice, black axis, green tea and aloe extract as an active ingredient, whitening effect, skin strength and wrinkle improvement effect Disclosed is a composition for improving skin having a composition.

상기와 같이 여러 식물에 대한 연구가 시행되고 있으나, 아직까지 새덕이나무를 이용한 화장료 조성물에 대한 연구는 시행된 바가 없다.As described above, studies on various plants have been conducted, but research on cosmetic compositions using Saeedok has not been conducted.

본 발명은 상기와 같은 문제를 해결하기 위하여, 자유 라디칼(free radical) 소거능, 엘라스테이즈 활성억제 효과, 티로시나아제 활성억제 효과 및 멜라닌 합성(melanogenesis) 저해효과를 갖는 새덕이나무 추출물(Neolitsea aciculata)을 함유하여 피부주름개선, 항산화활성 및 피부미백효과를 갖는 화장료 조성물을 제공하려는 목적이 있다.The present invention, in order to solve the above problems, free radical scavenging ability, elastase activity inhibitory effect, tyrosinase activity inhibitory effect and melanogenesis (melanogenesis) inhibitory effect ( Neolitsea aciculata It is an object to provide a cosmetic composition having a skin wrinkle improvement, antioxidant activity and skin whitening effect.

본 발명은 새덕이나무 추출물을 유효성분으로 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing the sapwood as an active ingredient.

본 발명의 새덕이나무 추출물은 메탄올 또는 에탄올 중에서 선택되는 어느 하나의 저급알코올로 추출한 후, 이를 극성이 다른 용매인 헥산, 에틸아세테이트, 부탄올, 물을 넣고 순차적으로 분획하여 제조하는 것으로 구성된다.The sapling tree extract of the present invention is prepared by extracting any one of lower alcohols selected from methanol or ethanol, and then dividing them sequentially by adding hexane, ethyl acetate, butanol, and water having different polarities.

본 발명에 대하여 보다 상세히 설명하면 다음과 같다.When described in more detail with respect to the present invention.

본 발명은 새덕이나무 추출물을 유효성분으로 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing the sapwood as an active ingredient.

새덕이나무(Neolitsea aciculata)는 원산지가 한국이며, 일본 및 우리나라 제주도와 울릉도, 남부지역의 습지에 자생한다. Neolitsea aciculata is native to Korea and grows in wetlands of Jeju, Ulleungdo, and southern part of Japan and Korea.

새덕이나무는 녹나무과인 상록교목으로 잎은 호생하며 가지 끝에 밀생. 도란상 타원형. 가장자리는 밋밋하고 끝이 뾰족하며 광택이 나고, 뒷면은 흰빛이 돌며 털은 없다. Saeedok is an evergreen tree, a camphor tree, whose leaves are regenerated and grow at the ends of branches. Oval-shaped oval. The edges are flat, pointed and glossy, and the back is white and hairless.

흰새덕이나무라고도 하며 흔히 새덕이 잎, 수피 및 열매를 건위 및 소화제로 이용한다.Also known as the white-backed wood, it often uses leaves, bark, and fruit as dry and digestive agents.

본 발명의 발명자들은 청정지역인 제주도 자생식물을 이용해서 산화작용을 차단하고, 산화 작용에 의해 유발되는 노화작용을 지연시키며, 피부의 색소 침착을 억제하기 위한 성분을 찾기 위하여 여러 제주 자생식물을 연구한 결과, 상기와 같은 효능을 가진 새덕이나무에서 우수한 항산화활성 효과, 주름 개선 및 탄력 증진 효과 뿐만 아니라 미백효과가 있음을 확인할 수 있었다. The inventors of the present invention study various Jeju native plants to find components for blocking oxidation, delaying aging caused by oxidation, and inhibiting pigmentation of skin using Jeju Island native plants, which are clean areas. As a result, it was confirmed that the whitening effect as well as excellent antioxidant activity, wrinkle improvement and elasticity enhancing effect in Saeedok with the above effects.

이러한 우수한 활성을 갖는 새덕이나무 추출물은 기능성 화장품 원료로의 응용이 가능하며, 천연식물을 사용함으로서 합성원료들로 야기되는 알러지 및 부작용, 안전성 및 안정성 면을 해결할 수 있음을 확인함으로서 본 발명을 완성하였다.Sadeokyi wood extract having such excellent activity can be applied as a functional cosmetic raw material, by completing the present invention by confirming that the use of natural plants can solve allergies and side effects, safety and stability caused by synthetic raw materials It was.

본 발명은 상기의 새덕이나무를 추출하여, 피부주름개선, 항산화활성 및 피부미백효과를 확인하였다.The present invention, the extract of the sakdeokgi, and confirmed the skin wrinkle improvement, antioxidant activity and skin whitening effect.

먼저, 본 발명은 새덕이나무 가지 중량의 약 10 ~ 40 배 부피의 용매를 사용하여 환류추출, 진탕추출 또는 에탄올추출 등의 방법에 의해 2 ~ 5회 반복 추출하고, 여과한 후 이 여액을 감압 건조하여 분말형태로 제조한다.First, the present invention is repeatedly extracted 2 to 5 times by a method such as reflux extraction, shaking extraction or ethanol extraction using a solvent of about 10 to 40 times the volume of the weight of the saengduk tree branches, filtered and reduced the filtrate It is dried and prepared in powder form.

상기 분말 형태로 제조된 추출물을 극성이 다른 용매인 헥산, 에틸아세테이 트, 부탄올, 물을 넣고 순차적으로 분획하여 생성된 분획추출물들을 감압 건조하여 분말형태로 제조한다.The extracts prepared in the form of powder are mixed with hexane, ethyl acetate, butanol, and water having different polarities, and sequentially fractionated. The extracts are dried under reduced pressure to prepare a powder form.

본 발명은 체계적인 방법으로 상기의 새덕이나무 추출물들이 DPPH(1,1-Diphenyl-2-picrylhydrazyl radical)법을 이용한 자유라디칼(Free radical)의 소거 활성을 나타낸다는 것을 확인하였으며, 특히 에틸아세테이트 분획추출물와 부탄올 분획추출물에서 높은 활성을 나타냄을 확인하였다.The present invention has been confirmed that the method of the method of extracting the Sapwood extract shows free radical scavenging activity using D PPH (1,1-Diphenyl-2-picrylhydrazyl radical) method, in particular ethyl acetate fraction It was confirmed that the extract and the butanol fraction extract showed high activity.

여기서 자유라디칼(Free radical)은 노화, 특히 피부노화의 원인물질로 알려진 것이다.Free radicals are known as the causative agents of aging, especially skin aging.

상기 피부노화, 특히 주름 생성에는 활성산소에 의한 작용과 매트릭스메탈로프로테이나제(matrix metalloproteinase(MMPs): collagenase, elastase 등)에 의한 세포외 매트릭스의 파괴가 주원인으로 간주되고 있다. The main cause of skin aging, particularly wrinkle formation, is the action of free radicals and the destruction of the extracellular matrix by matrix metalloproteinases (MMPs: collagenase, elastase, etc.).

따라서 MMPs의 저해활성 측정은 피부노화 억제 평가에 대단히 중요하다.Therefore, measurement of inhibitory activity of MMPs is very important for evaluation of skin aging inhibition.

이에, 본 발명에서는 새덕이나무 추출물들의 엘라스테이즈(Elastase) 저해활성에 대해 확인한 결과, 새덕이나무 추출물들이 엘라스테이즈 활성을 감소시키는 것을 확인하였으며, 특히 에틸아세테이트 분획추출물에서 높은 저해활성을 나타냄을 확인하였다.Therefore, in the present invention, as a result of confirming the elastase inhibitory activity of the Edelase extracts, it was confirmed that the Edelase extracts reduced the elastase activity, in particular, high inhibitory activity in the ethyl acetate fraction extract It was confirmed.

또한, 멜라닌은 L-티로신(L-tyrosine)을 기질로 하여 티로시나아제(tyrosinase)가 핵심효소로 작용하여 생성되기 때문에 본 발명에서는 새덕이나무 추출물들의 티로시나아제(tyrosinase) 활성 저해능력을 측정하였다.In addition, since melanin is produced by tyrosinase acting as a key enzyme using L-tyrosine as a substrate, in the present invention, melanin measures tyrosinase activity inhibitory ability of the extracts of Pleurotus eryngii. It was.

그 결과, 새덕이나무 추출물이 티로시나아제(Tyrosinase) 활성을 감소시키는 것을 확인하였으며, 특히 에틸아세테이트 분획추출물에서 높은 저해활성을 나타냄을 확인하였다.As a result, it was confirmed that S. aureus extract reduced Tyrosinase activity, in particular, ethyl acetate fraction extract showed a high inhibitory activity.

또한, 새덕이나무 추출물에 대한 세포내에서의 미백효과를 측정하기 위하여 B16-F10 세포배양 시스템을 이용한 멜라닌 합성(melanogenesis) 저해효과를 측정한 결과, 새덕이 에탄올추출물과, 헥산 분획추출물, 부탄올 분획추출물에서 높은 멜라닌합성 저해율을 나타냄을 확인하였다.In addition, as a result of measuring the melanogenesis inhibitory effect using the B16-F10 cell culture system in order to measure the whitening effect in the cell on the extract of Saengdeok tree, Saedok ethanol extract, hexane fraction extract, butanol fraction It was confirmed that the extract showed a high melanin synthesis inhibition rate.

이는 대조구(control)로 사용한 1mg/ml의 알부틴(arbutin)의 저해율 보다도 우수한 활성을 보여 흑색종 세포(melanoma cell)내에서의 미백활성은 알부틴(arbutin)보다 우수함을 알 수 있었다. This showed better activity than the inhibition rate of 1 mg / ml of arbutin used as a control, and the whitening activity in melanoma cells was better than that of arbutin.

또한, 본 발명인 새덕이나무 추출물들의 세포독성을 확인하기 위해 MTT 방법으로 확인한 결과, B16 흑색종 세포(melanoma cell)와 인간 섬유아세포(normal human fibroblast cell, NHF)에 대한 세포독성도 적어 새덕이나무 추출물을 첨가물로 하는 기능성 화장품 소재로의 개발이 가능하리라고 여겨진다.In addition, as a result of confirming by the MTT method to confirm the cytotoxicity of the extracts of the present invention Saeduk tree, Saedok tree with less cytotoxicity to B16 melanoma cells and normal human fibroblast cells (NHF) It is thought that the development of functional cosmetic material with an extract as an additive is possible.

이상과 같이, 본 발명의 새덕이나무 추출물은 항산화활성효과, 피부주름 개선효과, 피부미백효과가 탁월하여 식품첨가제, 음료조성물, 기능성 건강식품, 화장료조성물 등에 매우 유용하게 이용될 수 있다.As described above, the saeedodeok extract of the present invention is excellent in antioxidant activity, wrinkle improvement effect, skin whitening effect can be very useful for food additives, beverage compositions, functional health foods, cosmetic compositions and the like.

특히, 본 발명의 새덕이나무 추출물을 화장료 조성물의 유효성분으로 포함하여 사용될 시, 화장료 조성물 전체중량 대비 0.0001 ~ 10.0 중량 %가 함유되며, 바람직하게는 0.1 ~ 10.0 중량 % 함유되는 것을 특징으로 한다.In particular, when using the saengduk tree extract of the present invention as an active ingredient of the cosmetic composition, it contains 0.0001 to 10.0% by weight relative to the total weight of the cosmetic composition, preferably characterized in that it contains 0.1 to 10.0% by weight.

상기 추출물의 함량이 0.0001 중량% 미만인 경우에는 주름개선, 항산화활성 및 피부미백효과가 나타나지 않으며, 10 중량 % 이상인 경우에는 함유량 증가에 대한 효과 증대 정도가 미미하며, 제형상의 안정 및 안정성에 문제가 있으며 경제적이지도 못하다.When the content of the extract is less than 0.0001% by weight, no wrinkle improvement, antioxidant activity and skin whitening effect are observed, and when the content of the extract is more than 10% by weight, the effect of increasing the content is insignificant, and there is a problem in the stability and stability of the formulation. It is not economical.

또한, 본 발명의 화장료 조성물은 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 보다 상세하게는, 화장수, 에센스, 로션, 크림, 팩, 파운데이션, 젤, 연고 또는 스프레이의 제형으로 제조될 수 있다.In addition, the cosmetic composition of the present invention may be prepared in any formulation that is conventionally prepared, and more specifically, may be prepared in the form of a lotion, essence, lotion, cream, pack, foundation, gel, ointment or spray. .

또한, 약학적 조성물로 이용할 수 있으며, 약제학적 분야에서의 공지의 방법에 의해 제조될 수 있고, 그 자체 또는 약학적으로 허용되는 담체, 부형제, 희석제 등과 혼합하여 분말, 과립, 정제, 캡슐제 또는 주사제 등의 제형으로 제조되어 사용될 수 있고, 이들은 경구 또는 비경구로 투여될 수 있다.It may also be used as a pharmaceutical composition, may be prepared by methods known in the pharmaceutical art, and may be mixed with itself or with a pharmaceutically acceptable carrier, excipient, diluent, or the like to form a powder, granule, tablet, capsule or It may be prepared and used in the form of an injection or the like, and they may be administered orally or parenterally.

본 발명에 따른 새덕이나무 추출물의 유효 투여량은 체내에서 활성성분의 흡수도, 불활성화율 및 배설속도, 환자의 연령, 성별 및 상태, 치료할 질병의 중증 정도 등에 따라 적절히 선택될 수 있다.The effective dosage of the sapling extract according to the present invention may be appropriately selected depending on the absorbency, inactivation rate and excretion rate of the active ingredient in the body, the age, sex and condition of the patient, the severity of the disease to be treated.

본 발명에 의해, 피부주름개선, 항산화활성 및 피부미백효과를 갖는 새덕이나무 추출물(Neolitsea aciculata)을 유효성분으로 함유하는 화장료 조성물이 제공된다.According to the present invention, there is provided a cosmetic composition containing as an active ingredient the extract of Neophyllum ( Neolitsea aciculata ) having skin wrinkle improvement, antioxidant activity and skin lightening effect.

이하, 본 발명에 대하여 실시예 및 실험예를 통하여 보다 상세히 설명하나, 이들이 본 발명의 범위를 제한하는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples, but these do not limit the scope of the present invention.

<실시예 1> 본 발명의 새덕이나무 추출물 제조1<Example 1> Preparation of Saeedopwood extract of the present invention 1

새덕이나무(Neolitsea aciculata) 가지는 한라수목원에서 제공받아 준비하였다. Neolitsea aciculata branches were prepared from Halla Arboretum.

준비한 새덕이나무 가지 1 kg을 잘게 자른 후, 이를 80 % 에탄올 40 ℓ에 넣고 일주일 동안 침적시킨 후 여과하였다. After cutting 1 kg of the prepared saengdeok tree branch, it was put in 40 L of 80% ethanol and soaked for 1 week, and filtered.

여과하여 걸러진 이 여액을 감압 건조하여 분말형태인 새덕이나무 에탄올 추출물을 준비하였다.The filtered filtrate was filtered and dried under reduced pressure to prepare a ethanol extract of sapling as a powder.

<실시예 2> 본 발명의 새덕이나무 추출물 제조2<Example 2> Preparation of Saeedopwood extract of the present invention 2

새덕이나무(Neolitsea aciculata) 가지는 한라수목원에서 제공받아 준비하였다. Neolitsea aciculata branches were prepared from Halla Arboretum.

준비한 새덕이나무 가지 1 kg을 잘게 자른 후, 이를 80 % 에탄올 40 ℓ에 넣고 일주일 동안 침적시킨 후 여과하였다. After cutting 1 kg of the prepared saengdeok tree branch, it was put in 40 L of 80% ethanol and soaked for 1 week, and filtered.

상기 여과하여 걸러진 이 여액에 극성이 다른 용매인 헥산, 에틸아세테이트, 부탄올, 물을 넣고 순차적으로 분획하여 생성된 분획추출물 중 헥산 분획추출물을 감압 건조하여 분말형태인 새덕이나무 헥산분획추출물을 준비하였다.The filtered filtrate was filtered, and hexane, ethyl acetate, butanol, and water having different polarities were added thereto, and the hexane fraction extract was dried under reduced pressure. The hexane fraction extract was prepared in powder form. .

<실시예 3> 본 발명의 새덕이나무 추출물 제조3<Example 3> Saeedok extract of the present invention 3

실시예 2와 같은 방법으로 제조하되, 분획추출물 중 에틸아세테이트 분획추출물을 감압 건조하여 분말형태인 새덕이나무 에틸아세테이트 분획추출물을 준비하였다.Prepared in the same manner as in Example 2, ethyl acetate fraction extract of the fraction extracts were dried under reduced pressure to prepare a ethyl acetate fraction extract of sapling wood powder.

<실시예 4> 본 발명의 새덕이나무 추출물 제조4<Example 4> Preparation of Saeedopwood extract of the present invention 4

실시예 2와 같은 방법으로 제조하되, 분획추출물 중 부탄올 분획추출물을 감압 건조하여 분말형태인 새덕이나무 부탄올 분획추출물을 준비하였다.Prepared in the same manner as in Example 2, the butanol fraction extract of the fraction extract was dried under reduced pressure to prepare a powdery sapling butanol fraction extract.

<실시예 5> 본 발명의 새덕이나무 추출물 제조5<Example 5> Preparation of Saeedopwood extract of the present invention 5

실시예 2와 같은 방법으로 제조하되, 분획추출물 중 물 분획추출물을 감압 건조하여 분말형태인 새덕이나무 물 분획추출물을 준비하였다.Prepared in the same manner as in Example 2, the water fraction extract of the fraction extract was dried under reduced pressure to prepare a water extract of Saeduk wood in powder form.

<실시예 6> 새덕이나무 추출물이 함유된 화장료 조성물의 제조<Example 6> Preparation of the cosmetic composition containing the sapwood extract

통상적인 화장료 조성물에 화장료 조성물 전체중량대비 상기의 실시예 4의 화장료 조성물 10 중량% 첨가하여 사용하였다.The conventional cosmetic composition was used by adding 10% by weight of the cosmetic composition of Example 4 to the total weight of the cosmetic composition.

<실험예 1> 본 발명인 새덕이나무 추출물의 DPPH법을 이용한 자유 라디칼(Free radical) 소거활성 측정실험Experimental Example 1 Experiment of Determination of Free Radical Scavenging Activity by DPPH Method

1. 실험방법1. Experimental method

자유 라디칼 소거 활성 측정을 위해 0.2mM DPPH를 메탄올에 용해시키고, 여 기에 각 시료들을 첨가한 후, 스펙트로포토메터(spectrophotometer)로 517nm에서 흡광도를 측정하였다. 0.2 mM DPPH was dissolved in methanol for free radical scavenging activity, and each sample was added thereto, and then absorbance was measured at 517 nm with a spectrophotometer.

시료를 넣지 않은 경우를 대조군으로 하고 시료를 넣은 것(실시예 1, 2, 3, 4, 5의 추출물)을 실험군으로 하여 저해율을 측정하였다. The inhibition rate was measured using the case where no sample was added as a control and the sample (extract of Example 1, 2, 3, 4, 5) as the experimental group.

소거 활성은 DPPH의 농도가 50% 감소되는데 필요한 시료의 농도(free radical scavenging activity: SC50, μg/ml)로 표시하였다. Scavenging activity was expressed as the concentration of the sample (free radical scavenging activity (SC 50 , μg / ml) required to reduce the DPPH concentration by 50%).

프리라디칼 소거능(%)식은 아래와 같다.The free radical scavenging ability (%) is as follows.

= [1-(A-A')/(B-B')]×100= [1- (A-A ') / (B-B')] × 100

A: 시료를 첨가한 반응용액의 517nm에서 흡광도A: absorbance at 517 nm of the reaction solution to which the sample was added

A': DPPH를 첨가하지 않은 반응용액의 517nm에서 흡광도A ': absorbance at 517 nm of the reaction solution without DPPH

B: 시료를 첨가하지 않은 반응용액의 517nm에서 흡광도B: absorbance at 517 nm of reaction solution without sample

B': 시료와 DPPH를 첨가하지 않은 반응용액의 517nm에서 흡광도B ': absorbance at 517 nm of sample and reaction solution without DPPH

2. 실험결과2. Experimental Results

상기 실험결과, 아래의 표 1과 같이 나타났다.As a result of the experiment, shown in Table 1 below.

SC50(μg/ml)SC 50 (μg / ml) 실시예 1(EtOH)Example 1 (EtOH) 20.5520.55 실시예 2(Hex)Example 2 (Hex) 161.1161.1 실시예 3(EtOAc)Example 3 (EtOAc) 13.9613.96 실시예 4(BuOH)Example 4 (BuOH) 12.6812.68 실시예 5(Water)Example 5 (Water) 76.6176.61

상기 표 1에 나타나 있듯이, 실시예 1의 추출물(에탄올 추출)의 SC50는 20.55 μg/ml, 실시예 2의 추출물(헥산 분획)은 161.1 μg/ml, 실시예 3의 추출물(에틸아세테이트 분획)은 13.96 μg/ml, 실시예 4의 추출물(부탄올 분획)은 12.68 μg/ml, 실시예 5의 추출물(물 분획)은 76.61 μg/ml로 나타남을 확인하였다.As shown in Table 1, the SC 50 of the extract of Example 1 (ethanol extract) is 20.55 μg / ml, the extract of Example 2 (hexane fraction) is 161.1 μg / ml, the extract of Example 3 (ethyl acetate fraction) Silver 13.96 μg / ml, Example 4 extract (butanol fraction) was 12.68 μg / ml, Example 5 extract (water fraction) was found to be 76.61 μg / ml.

이에, 본 발명의 추출물 모두에게 자유 라디칼(free radical) 소거활성이 나타났으며, 특히 실시예 3, 4의 추출물에서 높은 활성을 나타냄을 알 수 있었다.Thus, free radical scavenging activity was observed in all of the extracts of the present invention, and it was found that the extracts of Examples 3 and 4 exhibited high activity.

<실험예 2> 본 발명인 새덕이나무 추출물의 엘라스테이즈(Elastase) 저해활성 측정실험Experimental Example 2 Measurement Test of Elastase Inhibitory Activity of the Investigator Sae-duk-Tak Extract

1. 실험방법1. Experimental method

0.2M Tris-Cl(pH 8.0), 0.3mM 엘라스테이즈(Elastase) 기질인 SANA (N-succinyl-(Ala)3-p-nitroanilide)에 각 시료들을 농도별로 첨가한 후 상온에서 10 분동안 배양(preincubation)한 후 엘라스테이즈(Elastase)를 첨가하여 10 분동안 상온에서 반응 후 410 nm에서 흡광도를 측정하였다. Each sample was added to 0.2 M Tris-Cl (pH 8.0) and 0.3 mM Elastase substrate SANA (N-succinyl- (Ala) 3-p-nitroanilide), followed by incubation at room temperature for 10 minutes. After preincubation, Elastase was added to measure the absorbance at 410 nm after reaction at room temperature for 10 minutes.

대조군은 시료 대신 시료용액으로 사용된 용매를 첨가한 것으로 하였으며, 실험군은 시료인 실시예 1, 2, 3, 4, 5의 추출물로 하여 저해율을 측정하였다. The control group was added to the solvent used as the sample solution instead of the sample, the experimental group was measured the inhibition rate as the extract of Examples 1, 2, 3, 4, 5 as the sample.

엘라스테이즈(Elastase) 저해활성은 엘라스테이즈의 활성을 50% 감소시키는데 필요한 시료의 농도(inhibition concentration, IC50, μg/ml)로 표기하였다.Elastase inhibitory activity was expressed as the concentration of the sample (IC 50 , μg / ml) required to reduce the activity of the elastase by 50%.

엘라스테이즈 저해율(%)식은 아래와 같다.Elastase inhibition rate (%) formula is as follows.

= [1-(각 시료의 효소 활성도)/(대조군의 효소활성도)]×100= [1- (enzyme activity of each sample) / (enzyme activity of control)] × 100

2. 실험결과2. Experimental Results

상기 실험결과, 아래의 표 2에 나타내었다.The experimental results are shown in Table 2 below.

IC50(μg/ml)IC 50 (μg / ml) 실시예 1(EtOH)Example 1 (EtOH) 8181 실시예 2(Hex)Example 2 (Hex) ndnd 실시예 3(EtOAc)Example 3 (EtOAc) 119119 실시예 4(BuOH)Example 4 (BuOH) 195195 실시예 5(Water)Example 5 (Water) 10171017

상기 표 2에 나타나 있듯이, 새덕이나무 추출물들(실시예 1,2,3,4,5)의 엘라스테이즈(Elastase) 저해활성을 측정한 결과, 실시예 1의 추출물(에탄올 추출)경우 IC50이 81μg/ml, 실시예 2의 추출물(hexane 분획)은 활성을 나타내지 않았고, 실시예 3의 추출물(ethyl acetate 분획)은 119μg/ml, 실시예 4의 추출물(butanol 분획)은 195μg/ml, 실시예 5의 추출물(물 분획)은 1017μg/ml을 나타냄을 확인하였다.As shown in Table 2, as a result of measuring the elastase (Elastase) inhibitory activity of Saddockwood extracts (Examples 1,2,3,4,5), the extract of Example 1 (ethanol extract) IC 50 was 81 μg / ml, the extract of Example 2 (hexane fraction) showed no activity, the extract of Example 3 (ethyl acetate fraction) was 119 μg / ml, the extract of Example 4 (butanol fraction) was 195 μg / ml, It was confirmed that the extract (water fraction) of Example 5 exhibited 1017 μg / ml.

상기 결과에 따라, 본 발명의 새덕이나무 추출물들 중 실시예 3의 추출물에서 엘라스테이즈(elastase) 저해활성이 가장 높게 나타남을 알 수 있었다.According to the above results, it could be seen that the elastase inhibitory activity was the highest in the extract of Example 3 of the saplings of the present invention.

<실험예 3> 본 발명인 새덕이나무 추출물의 티로시나아제(Tyrosinase) 저해활성 측정실험Experimental Example 3 Test of Tyrosinase Inhibitory Activity of the Extract of the Shingulus japonicus of the Present Invention

1. 실험방법1. Experimental method

0.1M potassium phosphate buffer(pH6.8), 0.2mM tyrosine, 1250 unit의 티로시나아제(Tyrosinase)를 각 시료들의 농도별로 첨가한 후 37 ℃에서 10 분간 반응 시킨 후 475 nm에서 흡광도를 측정한다. 0.1M potassium phosphate buffer (pH6.8), 0.2mM tyrosine, and 1250 units of tyrosinase were added for each concentration of the sample, followed by reaction at 37 ° C for 10 minutes, and then absorbance at 475 nm.

시료를 넣지 않은 경우를 대조군으로 하고 시료를 넣은 것(실시예 1, 2, 3, 4, 5의 추출물)을 실험군으로 하여 저해율을 측정하였다. The inhibition rate was measured using the case where no sample was added as a control and the sample (extract of Example 1, 2, 3, 4, 5) as the experimental group.

티로시나아제(Tyrosinase) 저해활성은 tyrosinase의 활성을 50% 감소시키는데 필요한 시료의 농도(inhibition concentration, IC50, μg/ml)로 표기하였다.Tyrosinase inhibitory activity was expressed as the concentration of the sample (IC 50 , μg / ml) required to reduce the tyrosinase activity by 50%.

티로시나아제 저해율(%)식은 아래와 같다.The tyrosinase inhibition rate (%) formula is as follows.

= [(A-B)/A]×100= [(A-B) / A] × 100

A: 시료를 첨가하지 않은 반응용액의 475nm에서 흡광도A: Absorbance at 475 nm of reaction solution without sample

B: 시료를 첨가한 반응용약의 475nm에서 흡광도B: absorbance at 475 nm of the reaction solution to which the sample was added

2. 실험결과2. Experimental Results

상기 실험결과, 아래의 표 3에 나타내었다.The experimental results are shown in Table 3 below.

IC50(μg/ml)IC 50 (μg / ml) 실시예 1(EtOH)Example 1 (EtOH) 562562 실시예 2(Hex)Example 2 (Hex) ndnd 실시예 3(EtOAc)Example 3 (EtOAc) ndnd 실시예 4(BuOH)Example 4 (BuOH) 211211 실시예 5(Water)Example 5 (Water) 11211121

상기 표 3에 나타나 있듯이, 멜라닌 생성의 중요한 역할을 하는 티로시나아제 저해활성을 측정한 결과, 실시예 1의 추출물(에탄올 추출)의 경우 IC50이 562 μg/ml, 실시예 2의 추출물(hexane 분획)과 실시예 3의 추출물(ethyl acetate 분획)에서는 mushroom tyrosinase 저해활성을 확인할 수 없었고, 실시예 4의 추출물(butanol 분획)의 경우에는 211 μg/ml, 실시예 5의 추출물(물 분획)에서의 경우 1121 μg/ml을 나타내었다. As shown in Table 3, as a result of measuring the tyrosinase inhibitory activity that plays an important role in the production of melanin, in the case of the extract of Example 1 (ethanol extraction) IC 50 is 562 μg / ml, the extract of Example 2 (hexane Fractions) and the extract of Example 3 (ethyl acetate fraction) could not confirm the mushroom tyrosinase inhibitory activity, the extract of Example 4 (butanol fraction) 211 μg / ml, the extract of Example 5 (water fraction) In the case of 1121 μg / ml.

이에, 티로시나아제 저해활성의 경우 실시예 4의 추출물(butanol 분획)에서의 활성이 가장 높게 나타냄을 알 수 있었다.Thus, the tyrosinase inhibitory activity was found to be the highest in the extract of Example 4 (butanol fraction).

<실험예 4> 본 발명인 새덕이나무 추출물의 멜라닌 합성 저해효과 측정실험<Experiment 4> Measurement experiment of melanin synthesis inhibitory effect of the present invention Saeeduk

1. 실험방법1. Experimental method

새덕이나무 추출물에 대한 세포내에서의 미백효과를 측정하기 위하여 B16 melanoma 세포를 이용하여 melanogenesis 저해효과를 측정하였다. B16 melanoma cells were used to measure the inhibitory effect of melanogenesis.

6 well plate에 5 × 104 cells/ml이 되도록 세포를 분주하고, 37℃의 5% CO2 조건하에서 24h 배양 후 배지를 제거하였다. Cells were aliquoted to 5 × 10 4 cells / ml in 6 well plates and cultured for 24 h under 37% 5% CO 2 conditions.

D-phosphate buffered saline(D-PBS)으로 세척한 후 1μM α-MSH를 포함하는 배지로 교환 후 시료 추출물(실시예 1,2,3,4,5)을 농도별로 각각 첨가하여 3일간 배양하였다. After washing with D-phosphate buffered saline (D-PBS) and exchanged with a medium containing 1 μM α-MSH, sample extracts (Examples 1,2,3,4,5) were added to each concentration and incubated for 3 days. .

3일 동안 배양 후 배지를 제거한 후 D-PBS buffer로 세척한 후 트립신으로 처리하여 세포를 회수하였다. After culturing for 3 days, the medium was removed, washed with D-PBS buffer, and then treated with trypsin to recover cells.

회수된 세포는 1M NaOH 500 ㎕를 첨가하고 55℃에서 2시간 방치하여 세포내의 melnin을 얻었다. The recovered cells were added with 500 μl of 1M NaOH and left at 55 ° C. for 2 hours to obtain intracellular melnin.

이는 microplate reader기로 475nm에서 흡광도를 측정하였다.This was measured for absorbance at 475nm with a microplate reader.

대조군으로는 알부틴(arbutin)을 사용하였다.Arbutin was used as a control.

2. 실험결과2. Experimental Results

상기 실험결과, 도 1과 아래의 표 4에 나타내었다.As a result of the experiment, it is shown in Figure 1 and Table 4 below.

처리농도
(㎍/ml)
Treatment concentration
(Μg / ml)
멜라닌
생합성 억제율(%)
Melanin
% Biosynthesis inhibition rate
세포 생존율
(%)
Cell viability
(%)
대조구Control 100100 00 100100 알부틴Arbutin 10001000 8282 9494 실시예 1(EtOH)Example 1 (EtOH) 12.5
25
50
100
12.5
25
50
100
0
14
70.7
80
0
14
70.7
80
104
100
115
103
104
100
115
103
실시예 2(Hex)Example 2 (Hex) 12.5
25
50
100
12.5
25
50
100
0
80
88
92
0
80
88
92
91
79
70
62
91
79
70
62
실시예 4(BuOH)Example 4 (BuOH) 12.5
25
50
100
12.5
25
50
100
14
35
44
81
14
35
44
81
101
102
107
80
101
102
107
80
실시예 5(water)Example 5 (water) 12.5
25
50
100
12.5
25
50
100
0
0
3
40
0
0
3
40
100
99
99
99
100
99
99
99

상기 표 4와 도 1에 나타나 있듯이, 티로시나아제 효소 활성 저해율을 확인하고 B16 melanoma 세포를 이용하여 세포 내에서의 미백효과를 측정하였다.As shown in Table 4 and Figure 1, the inhibition rate of tyrosinase enzyme activity was confirmed, and the whitening effect was measured in cells using B16 melanoma cells.

실시예 1의 추출물(에탄올 추출)의 경우 100μg/ml에서 80%의 저해율을 보였고, 100μg/ml의 실시예 2의 추출물(hexane 분획)과 실시예 4의 추출물(butanol 분획)에서 80% 정도의 melanin 합성 저해율을 나타냈다.In the case of the extract of Example 1 (ethanol extraction) showed an inhibition rate of 80% at 100μg / ml, about 80% of the extract of Example 2 (hexane fraction) and the extract of Example 4 (butanol fraction) of 100μg / ml It showed melanin synthesis inhibition.

이는 대조군(control)으로 사용한 1000 μg/ml의 알부틴(arbutin)의 저해율과 비슷한 활성정도를 보여 melanoma 세포 내에서의 미백 활성은 알부틴보다 우수함을 알 수 있었다. This showed a similar activity to that of 1000 μg / ml of arbutin (arbutin) used as a control, indicating that the whitening activity in melanoma cells was better than that of arbutin.

또한 B16 melanoma 세포에 대한 세포독성도 적어 미백관련 화장품 소재로의 개발이 가능할 것으로 사료된다.In addition, the cytotoxicity against B16 melanoma cells is low, and thus it may be possible to develop a cosmetic material related to whitening.

<실험예 5> 본 발명인 새덕이나무 추출물의 MTT 방법에 의한 세포독성 평가 실험Experimental Example 5 Cytotoxicity Evaluation Experiment of M.D.

1. 실험방법1. Experimental method

MTT assay는 B16F10 melanoma cell과 NHF(normal human fibroblaste) cell을 24시간 배양 후 시료 추출물(실시예 1,2,3,4,5)들을 여러농도별로 처리한 후 2일간 배양 후 500μg/ml MTT(3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide)를 well 당 20㎕를 첨가하였다. In MTT assay, B16F10 melanoma cells and NHF (normal human fibroblaste) cells were incubated for 24 hours, and then sample extracts (Examples 1,2,3,4,5) were treated at various concentrations. 20 μl of 3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyl-2H-tetrazolium bromide) was added per well.

37℃에서 4시간 동안 반응 시킨 후 MTT 용액을 제거하고 well 당 DMSO 200㎕를 첨가하였다. After 4 hours of reaction at 37 ° C., the MTT solution was removed and 200 μl of DMSO was added per well.

살아있는 세포와 반응하여 생긴 formazan 침전물을 용해시킨 다음 microplate reader로 540nm에서 흡광도를 측정하였다. After dissolving the formazan precipitate produced by reacting with living cells, the absorbance was measured at 540 nm with a microplate reader.

2. 실험결과2. Experimental Results

상기 실험결과를 아래의 표 5와 도 2에 나타내었다.The experimental results are shown in Table 5 and FIG. 2 below.

처리농도
(㎍/ml)
Treatment concentration
(Μg / ml)
세포 생존율
(%)
Cell viability
(%)
대조구Control 100100 100100 실시예 1(EtOH)Example 1 (EtOH) 12.5
25
50
100
12.5
25
50
100
106
117
99
87
106
117
99
87
실시예 2(Hex)Example 2 (Hex) 12.5
25
50
100
12.5
25
50
100
88
64
52
31
88
64
52
31
실시예 3(EtOAc)Example 3 (EtOAc) 12.5
25
50
100
12.5
25
50
100
106
105
103
106
106
105
103
106
실시예 4(BuOH)Example 4 (BuOH) 12.5
25
50
100
12.5
25
50
100
110
105
96
86
110
105
96
86
실시예 5(water)Example 5 (water) 12.5
25
50
100
12.5
25
50
100
99
100
100
94
99
100
100
94

상기 표 2와 도 2에 나타나 있듯이, 인간 섬유아세포(Normal human fibroblast, NHF)에서의 세포독성을 확인한 결과, 특히 B16 melanoma 세포에서 우수한 활성을 보였던 실시예 4의 추출물(butanol 분획)에서는 세포독성도 거의 없어 앞으로 이를 이용한 기능성 화장품 소재개발에 유용하리라 사료되어 진다.As shown in Table 2 and Figure 2, as a result of confirming the cytotoxicity in the normal human fibroblast (NHF), in particular the extract (butanol fraction) of Example 4 showed excellent activity in B16 melanoma cells cytotoxicity It is thought that it will be useful for the development of functional cosmetic materials using it.

도 1은 B16-F10 세포배양 시스템에서 멜라닌 합성 저해효과를 나타낸 그래프.1 is a graph showing the melanin synthesis inhibitory effect in the B16-F10 cell culture system.

control : 대조군(시료를 첨가하지 않은 군)control: Control group (sample not added)

EtOH : 실시예 1의 추출물EtOH: Extract of Example 1

hex : 실시예 2의 추출물hex: Extract of Example 2

EtOAc: 실시예 3의 추출물EtOAc: extract of Example 3

BuOH : 실시예 4의 추출물BuOH: Extract of Example 4

DW : 실시예 5의 추출물DW: Extract of Example 5

도 2는 MTT 방법에 의한 세포독성를 나타낸 그래프.Figure 2 is a graph showing the cytotoxicity by the MTT method.

control : 대조군(시료를 첨가하지 않은 군)control: Control group (sample not added)

EtOH : 실시예 1의 추출물EtOH: Extract of Example 1

hex : 실시예 2의 추출물hex: Extract of Example 2

EtOAc: 실시예 3의 추출물EtOAc: extract of Example 3

BuOH : 실시예 4의 추출물BuOH: Extract of Example 4

DW : 실시예 5의 추출물DW: Extract of Example 5

Claims (6)

새덕이나무 추출물(Neolitsea aciculata)을 유효성분으로 함유하는 화장료 조성물.Cosmetic composition containing the extract of Neophyllum ( Neolitsea aciculata ) as an active ingredient. 제1항에 있어서,The method of claim 1, 상기 유효성분은 화장료 조성물의 총 중량대비 0.0001 ~ 10.0 중량 %로 포함되는 것을 특징으로 하는, The active ingredient is characterized in that it comprises 0.0001 ~ 10.0% by weight relative to the total weight of the cosmetic composition, 화장료 조성물.Cosmetic composition. 제1항에 있어서,The method of claim 1, 상기 새덕이나무 추출물은 피부주름개선, 항산화활성 및 피부미백효과를 갖는 것을 특징으로 하는, The sakura wood extract is characterized in that it has a skin wrinkle improvement, antioxidant activity and skin lightening effect, 화장료 조성물.Cosmetic composition. 제1항에 있어서,The method of claim 1, 상기 새덕이나무 추출물은 메탄올 또는 에탄올 중에서 선택되는 어느 하나의 저급알코올로 추출하여 제조된 것을 특징으로 하는, The sapwood extract is characterized in that it is prepared by extracting any one of lower alcohols selected from methanol or ethanol, 화장료 조성물.Cosmetic composition. 제1항에 있어서,The method of claim 1, 상기 새덕이나무 추출물은 메탄올 또는 에탄올 중에서 선택되는 어느 하나의 저급알코올로 추출한 후, 이를 극성이 다른 용매인 헥산, 에틸아세테이트, 부탄올, 물을 넣고 순차적으로 분획하여 생성된 분획추출물인 것을 특징으로 하는,The sapling tree extract is extracted with any one of lower alcohols selected from methanol or ethanol, and then fractions are produced by sequentially dividing them into hexane, ethyl acetate, butanol, water of different polarity , 화장료 조성물.Cosmetic composition. 제1항 내지 제5항에 있어서,The method according to claim 1, wherein 상기 화장료 조성물은 화장수, 에센스, 로션, 크림, 팩, 파운데이션, 젤, 연고 또는 스프레이로 구성된 군으로부터 선택되는 제형을 갖는 것을 특징으로 하는,The cosmetic composition is characterized in that it has a formulation selected from the group consisting of lotion, essence, lotion, cream, pack, foundation, gel, ointment or spray, 화장료 조성물.Cosmetic composition.
KR1020090010402A 2009-02-10 2009-02-10 Cosmetic composition included neolitsea aciculata extraction KR101100129B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020090010402A KR101100129B1 (en) 2009-02-10 2009-02-10 Cosmetic composition included neolitsea aciculata extraction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090010402A KR101100129B1 (en) 2009-02-10 2009-02-10 Cosmetic composition included neolitsea aciculata extraction

Publications (2)

Publication Number Publication Date
KR20100091284A true KR20100091284A (en) 2010-08-19
KR101100129B1 KR101100129B1 (en) 2011-12-29

Family

ID=42756491

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090010402A KR101100129B1 (en) 2009-02-10 2009-02-10 Cosmetic composition included neolitsea aciculata extraction

Country Status (1)

Country Link
KR (1) KR101100129B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160081445A (en) * 2014-12-31 2016-07-08 주식회사 유니솔브 A composition for antioxidating, whitening and improving wrinkle comprising extracts of false indigo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001226218A (en) * 2000-02-17 2001-08-21 Ichimaru Pharcos Co Ltd Cosmetic composition containing plant steam distillation water

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160081445A (en) * 2014-12-31 2016-07-08 주식회사 유니솔브 A composition for antioxidating, whitening and improving wrinkle comprising extracts of false indigo

Also Published As

Publication number Publication date
KR101100129B1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
KR102293081B1 (en) Cosmetic composition for skin moisturizing comprising Mixed extract of Moutan radiciscortex and fermentation
KR101155714B1 (en) Cosmetic composition containing immature fruit or seed extract of torreya nucifera
KR102348419B1 (en) Cosmetic composition containing ferment complex extracts of Pyrus Malu, Fragaria Ananassa and Sambucus Nigra
KR102373899B1 (en) Multifunctional cosmetic composition containing complex natural extracts effective for skin wrinkle improvement, whitening, cell regeneration, and wound healing as an active ingredient
KR102158780B1 (en) Composition for improving skin comprising natural material extract
KR102350857B1 (en) Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water
KR20130040316A (en) Cosmetics composites
KR101661545B1 (en) Cosmetic composition comprising an extracts of fermented rhodiola rosea having whitening activits
KR101995557B1 (en) Cosmetic composition including fermented water lily extract and method for manufacturing the same
KR101100129B1 (en) Cosmetic composition included neolitsea aciculata extraction
KR20090029873A (en) Cosmetic compositions used for antiaging and antiwrinkle
KR20010096669A (en) cosmetic composition containing plant extract complex
KR101441190B1 (en) Cosmetic composition containing Oreocnide fruticosa extraction
KR102471009B1 (en) Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles
CN113631227B (en) Anti-aging agent, antioxidant, anti-inflammatory agent, whitening agent, and cosmetic
KR20190018100A (en) Cosmetic composition for Antioxidant, anti-wrinkle, anti-inflammatory, skin-whitening and hair-growing active compounds derived from Acorus Calamus Root extract
KR100416400B1 (en) Composition containing extracts from dried roots of Trichosantes kirilowii maxim for external application and skin-whitening and process for preparation thereof
KR20030047680A (en) The Skin Lightening Cosmetic Composition Containing Extract Of Gardenia
KR101003470B1 (en) Cosmetic composition for antioxidation containing the extract of ancient rice
KR20220082192A (en) Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract
KR101398392B1 (en) cosmetic compositions containing extract of Viburnum dilatatum Thunb used for antiwrinkle
KR100967805B1 (en) cosmetic compositions containing extract of Ostrya japonica Sarg used for antiwrinkle
KR20200038114A (en) Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom
KR102079090B1 (en) Cosmetic composition containing Polygonum multiflorum stem extract
KR20090089982A (en) Cosmetic compositions containing extract of empetrum nigrum var. japonicum used for antiwrinkle

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20141201

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20151113

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20171218

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20190415

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20191127

Year of fee payment: 9